Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

ested to study Abbott's Bcl-2 family protein inhibitors, which is an indication of the potential value that ABT-263 might bring to the cancer research field," said John Leonard, M.D., senior vice president, Pharmaceuticals, Research and Development, Abbott. "We have built an early stage pipeline that targets the processes that cancers need to survive and we're looking forward to advancing our work in this area."

Presentation highlights include:

-- A Phase I Study Evaluating the Safety, Pharmacokinetics, and Efficacy

of ABT-263 in Subjects With Refractory or Relapsed Lymphoid

Malignancies

-- Reduction in Platelet Counts as a Mechanistic Biomarker and Guide for

Adaptive Dose-escalation in Phase I Studies of the Bcl-2 Family

Inhibitor ABT-263

-- Dynamic Contrast Enhanced MRI (DCE MRI) for Assessment of Effects of

Anti-Angiogenic Therapy: Comparison of the Transfer Constant (Ktrans)

to Blood Flow and Permeability Derived by a Distributed Parameter

Model

-- Relationship of Dose of ABT-869 on Biomarkers of Angiogenesis and

Their Correlation With Pharmacodynamic (PD) Outcome

Study Background and Results

ABT-263

Thirty patients with refractory or relapsed lymphoid malignancies have been enrolled in an ongoing Phase I study evaluating safety, pharmacokinetics and efficacy. Subjects received ABT-263 orally once daily for 14 consecutive days followed by seven days off drug in each cycle of therapy. Results showed that ABT-263 had an acceptable side-effect profile at the seven-dose (10, 20, 40, 80, 160, 225 and 315 mg) cohort levels and showed evidence of anti-tumor activity. Researchers observed 99 percent and 36 percent tumor reduction in two patients with bulky chronic lymphocytic leukemia (CLL). Another patient with bulky CLL/small lymphocytic lymphoma (SLL) experienced a 75 percent reduction and a patient with follicular lymphom
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... 21, 2014 (HealthDay News) -- Close friends have more ... group does, a new study says. "We,ve ... have an influence on individual alcohol use, but there ... peer group and the friend group,s influence on those ... School of Public Health, said in a university news ...
(Date:11/23/2014)... To show thanks to new and old customers, iFitDress.com ... dresses for weddings. Customers who need custom outfits can ... distinguished dress manufacturer, and it is among the ones which ... very long time. The CEO of this company says, "iFitDress.com ... to buy not only a beautiful dress, but also a ...
(Date:11/23/2014)... CA (PRWEB) November 23, 2014 ... American Medical Aesthetics & Wellness was recently featured ... Milgrom, Ph.D. is president and CEO of American Medical ... Dr. Asher Milgrom received a full scholarship to attend ... the Medical School at the University of Chicago, where ...
(Date:11/23/2014)... Wright & Schulte LLC recently filed 40 C8 ... residents who allege that they developed thyroid disease, high ... C8 contaminated water released by the DuPont Washington ... C8 complaints, the plaintiffs were exposed to the C8 ... least one of the six water districts affected by ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 A new ... its doors in the downtown Greenville area. Dr. Chelsea ... Greenville , decided to open her own clinic after ... results with the patients. , AlignLife believes that ... tools. With a focus on chiropractic care and rehabilitation ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2
... , CALL DATE: ... TIME: 8:30 a.m. Eastern ... Dr. Candace Kendle, Chairman and CEO Kendle ... at 8:30 a.m. Eastern Time to discuss its,financial results for the Fourth Quarter and ...
... Stryker Corporation,(NYSE: SYK ) announced today that it ... at 8:00 a.m. Eastern Time, in New York, New ... Officer, will host,the meeting with presentations by leaders of ... the meeting will be available on Stryker,s,website at ...
... 30 Crowell & Moring LLP is,pleased to announce ... New,York office as a member of the firm,s Antitrust ... where she helped found and co-chair,the firm,s Healthcare Industry ... Federal Trade Commission (FTC), where she investigated and,prosecuted mergers, ...
... Jan. 30 More than 100 local VIPS,physicians and ... of America (DCA) Delray Beach medical facility to commemorate ... imaging, enabling physicians to obtain clearer images of the ... without the need for beta blockers., Mayor Rita ...
... Partners Purchase Interest from American ... Securities Capital Partners, ... Ganey,Associates, Inc., the leading provider of health care performance,improvement solutions, ... a majority interest in the Company from,long-time investor American Securities ...
... SILVER SPRING, Md., Jan. 30 Expanding the,pipeline ... for Microbicides (IPM) today announced that Pfizer Inc.,(Pfizer) ... to maraviroc, its,newly-approved HIV treatment, as a microbicide ... the trade name Selzentry(TM)/Celsentri(R),is one of a new ...
Cached Medicine News:Health News:Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 2Health News:Stryker to Host Analyst Meeting 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 3Health News:Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with World's Most Advanced Cardiac Scanner. 2Health News:Press Ganey Takes on New Investment Partner 2Health News:Press Ganey Takes on New Investment Partner 3Health News:Press Ganey Takes on New Investment Partner 4Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 2Health News:IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide 3
(Date:11/22/2014)... , Nov. 21, 2014   Long Beach dentist ... are often called the gold standard in tooth replacement because ... a stable, long-lasting way to restore and preserve smiles and ... to replace a missing tooth or as a part of ... the look and feel of a smile. The ...
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, Inc ... has developed and manufactured a new innovative vaginal ... Research and Development arm of Exeltis Pharmaceuticals.  According ... Project Management at Particle Sciences, "This vaginal ring ... our material sciences and modeling expertise.  We are ...
(Date:11/21/2014)... Mass. , Nov. 21, 2014  Alere Inc. ... rapid diagnostic tests, has appointed Juliet Cunningham ... role, Cunningham will be responsible for driving communications with ... execute on a series of changes to increase shareholder ... progress to investors," said Namal Nawana, Chief Executive Officer. ...
Breaking Medicine Technology:Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... , Feb. 16 The AccuVein AV300 has been ... New Products for Pediatricians" as part of the magazine,s annual new ... edition, in print and online, stated that the AV300 would ... or pediatric ICU." , Written by Dr. Andrew J. Schuman ...
... MOUNTAIN VIEW, Calif. , Feb. 16 Alexza Pharmaceuticals, Inc. ... meeting on Thursday, February 18, 2010 from 9:00 a.m. ... The meeting will include presentations from: , Thomas King ... , PhD - SVP, Research and Development, Alexza Pharmaceuticals Michael ...
Cached Medicine Technology:AccuVein AV300 Named a 'Best New Product' by Contemporary Pediatrics 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4
Glass Whole Blood Tube with K3EDTA...
... (tTg) is a ubiquitous enzyme that ... transglutaminase is also the specific protein ... antibody immunofluorescence (EMA) tests (Bio-Rad catalog ... and,IgG serologic tests are highly sensitive ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: